Numinus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29thThe Psychedelic Sector Has Come Back To Life After A Very Challenging Couple Of YearsBraxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial KetaField Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness LPSYC Has Been Hitting Some Major Company Milestones Over The Last MonthPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Third Consecutive MonthCognetivity Neurosciences Launches Paid Pilot Project with MS&AD Group CompaniesField Trip Announces First Dosings in Phase I Clinical Study of FT-104PSYC Corporation Has Been Seeing A Favorable Response From The Market Following Several Positives Milestones Being HitNuminus Wellness Is One Of The Bright Spots Of The Psychedelic Sector
Back

PSYC Has Been Hitting Some Major Company Milestones Over The Last Month

Aug 8, 2022 • 7:40 AM EDT
5 MIN READ  •  By Anthony Varrell
Share Share - Facebook Share - Twitter

Although 2022 has proven to be a challenging period for the psychedelic sector, several public companies have recently started to trend higher. What makes us even more excited about the turnaround is related to how trading volume has increased for several of these firms. 

While many investors believe that a stock’s price is the most important data point for any public company, we consider trading volume to be just as significant. If a stock does not trade many shares per day, the selling process is more challenging for the investor. When trading volume is high, that means there is a lot of interest in buying the stock in question.

A few months ago, we highlighted PSYC Corporation (OTC Pink: PSYC) as a psychedelic business with a favorable risk-reward profile and a compelling valuation. Since publishing our first article on the psychedelic media firm, the stock has been trending higher on a greater-than-normal trading volume. 

In July, PSYC reported more than one million page views for Psychedelic Spotlight. With this achievement, the company has reached this milestone for its the third consecutive month and reported a record number of page views, impressions, unique visitors, and the highest click through rate (CTR).

During the last two years, Psychedelic Spotlight has evolved from a niche website to a destination for industry information from a diverse group of experts and analysts. The evolution of the platform into a leading information portal for the psychedelics sector is a testament to the strength of the management team as well as their ability to execute. 

During the last month, PSYC seems to have found stability in a higher trading range and we find this to be significant. The next few months will be play a vital role when it comes to analyzing the performance of the stock  for the 2022 calendar year. At current levels, we continue to believe that PSYC has considerable upside potential and significant growth catalysts. 

An Execution and Growth Story

From a communication standpoint, the psychedelic media firm has greatly improved how it updates the market on the advancement of the business. During the last quarter, PSYC has made the following announcements:

  1. August 3rd – For the third consecutive month, PSYC reported more than 1 million page views for Psychedelic Spotlight and has recorded strong improvements from an engagement standpoint
  2. July 19th – Strengthened the balance sheet by announcing the consolidation of 49 previously issued convertible debentures to RB Capital
  3. July 6th – The firm issued an update on the joint venture with Digital Acorn for the ongoing co-development of PsycheDev, a digital mental health platform.
  4. June 29th – The company said its $125,000 investment (made in January 2021) in The Conscious Fund has earned an unrealized gain of nearly 30% as of early June 2022.
  5. May 24th – The psychedelic news and information platform formed a collaborative partnership agreement with The Spore Group (TSG) to produce conferences and events for the emerging psychedelic sector.

We believe the continued execution by the management team is a testament to the strength of the business. We are of the opinion that the management team is working to maximize shareholder value by executing on a multi-faceted expansion strategy comprised of a series of organic and inorganic growth projects. 

PSYC’s management team seems to have its finger on the pulse of the psychedelic sector and we are bullish on how the story has advanced so far this year. From acquiring strategic assets to adding important human capital to the leadership team, we are favorable on the direction the business is heading and believe our readers should be aware of the opportunity. 

If you are interested in learning more about PSYC Corporation, please send an email to support@mushroomstocks.com with the subject “PSYC Corporation” to be added to our distribution list.

About PSYC Corporation (OTCPink: PSYC)

At PSYC Corporation we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We are dedicated to a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future.

 

 

 

 

 

 

 

 

Pursuant to an agreement between StoneBridge Partners LLC and PSYC Corporation we have been hired for a period of 90 days beginning May 9, 2022 and ending August 9, 2022 to publicly disseminate information about (PSYC) including on the Website and other media including Facebook and Twitter. We are being paid $5,000 per month (PSYC) for or were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of (PSYC) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (PSYC) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share Share - Facebook Share - Twitter

Tags

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Comments

Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link